摘要
结核病防控工作亟待创新性的研究与发展,以加快实现终止结核病策略。2022年10月27日,世界卫生组织发布了《2022年全球结核病报告》,对全球结核病领域的研究和创新进展进行更新。笔者就报告中结核病研究领域新诊断技术、新药与新方案,以及新疫苗等研究及创新要点进行解读,并结合我国相关领域的研究进展进行分析,以期为我国结核病防治领域同行掌握结核病研究动态,进一步开展原创性科研和创新提供参考。
Tuberculosis(TB)prevention and control work needs innovative research and development to accelerate the implementation of the World Health Organization(WHO)End TB Strategy.On 27th October 2022,WHO released the Global Tuberculosis Report 2022,updating the latest progress of global TB research and innovation.This paper reviews the key achievements in the areas of research and innovation for new diagnostics,drugs and regimens as well as vaccines introduced in the report,and discusses some of China’s indigenous progresses in related areas.This paper aims to make China’s TB professionals better informed about the latest research development in TB prevention and control around the globe,fostering indigenous TB innovation efforts with greater originality.
作者
舒薇
刘宇红
Shu Wei;Liu Yuhong(Beijing Chest Hospital,Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute/Clinical Center on Tuberculosis,China CDC,Beijing 101149,China)
出处
《中国防痨杂志》
CAS
CSCD
2023年第5期454-457,共4页
Chinese Journal of Antituberculosis
基金
2022—2023年度北京市卫生健康委世界卫生组织合作中心择优支持项目。
关键词
结核
研究
总结性报告
Tuberculosis
Research
Consensus development conference
